|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, April 20, 2017 ) The global cervical cancer diagnostic testing market is growing steadily, primarily due to the availability and awareness of the programs in the developed countries. This test enables women aged 21 years and above to get screened, making most of the pre-cancerous lesions identifiable at stages when they can be treated easily. In the US, National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides low-cost even free cervical cancer screening for uninsured and low-income women. As per the Affordable Care Act, all health insurance plans initiated after September 23, 2010, should provide recommended cervical cancer screening tests to end-users. In developing countries, with the widespread awareness programs by public organizations like the WHO along with government initiatives, visual inspection with acetic acid (VIA) and Lugol's iodine (VILI) are being performed to screen women. This initiative is expected to raise the market demand for cervical cancer screening and diagnostic tests.
Publisher's analysts forecast the global cervical cancer diagnostic testing market to grow at a CAGR of 6.90% during the period 2016-2020.
For more information about this report: http://www.reportsweb.com/global-cervical-cancer-diagnostic-testing-market-2016-2020 .
Covered in this report
The report covers the present scenario and the growth prospects of the global cervical cancer diagnostic testing market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cervical cancer testing products used to perform cervical cancer screening.
The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA
Publisher's report, Global Cervical Cancer Diagnostic Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
-Abbott Molecular
-Becton
-Dickinson & Company
-Hologic
-Qiagen
-Quest Diagnostics
-Roche Molecular Diagnostics
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001502512/sample .
Other prominent vendors
-Arbor Vita
-Autogenomics
-bioMérieux
-BioVantra
-Cancer Genetics
-Cepheid
-Cervia Diagnostics
-Cytoimmun
-DAAN Gene
-Delphi Bioscience
-DiaCarta
-Fujirebio
-Genera Biosystems
-Greiner Bio-One
-Guided Therapeutics
-GynaeHealth
-IncellDx
-Micromedic Technologies
-Norchip
-OncoHealth
-OralDNA Labs
-Seegene
-Solopap International
-Trovagene
Market driver
-Increasing global activities by public organizations.
-For a full, detailed list, view our report
Market challenge
-Rising awareness toward cervical cancer over-screening.
-For a full, detailed list, view our report
Market trend
-Development of new diagnostic platforms.
-For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001502512/buying .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
